Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:glycopyrrolate 0.2mg/ml inj,syringe,3ml'
(id=6948863 ; fe=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2729 creation date=2017-06-25 touchdate=2025-11-02 23:18:44.000)
≈ 30 relations sortantes

  1. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 30 / 1 -> en:tachycardia
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:tachycardia | rel=r_associated | relid=0 | w=30
  2. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 21 / 0.7 -> en:angle closure glaucoma
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:angle closure glaucoma | rel=r_associated | relid=0 | w=21
  3. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> battement rapide du coeur
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=battement rapide du coeur | rel=r_associated | relid=0 | w=20
  4. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> colite ulcéreuse chronique
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=colite ulcéreuse chronique | rel=r_associated | relid=0 | w=20
  5. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:bowel obstruction
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:bowel obstruction | rel=r_associated | relid=0 | w=20
  6. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:decreased respiratory secretions
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:decreased respiratory secretions | rel=r_associated | relid=0 | w=20
  7. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:glycopyrrolate 100%w/w powder
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:glycopyrrolate 100%w/w powder | rel=r_associated | relid=0 | w=20
  8. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:glycopyrrolate 1mg tablet
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:glycopyrrolate 1mg tablet | rel=r_associated | relid=0 | w=20
  9. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:glycopyrrolate 2mg tablet
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:glycopyrrolate 2mg tablet | rel=r_associated | relid=0 | w=20
  10. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:glycopyrrolate and neostigmine bromide product
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:glycopyrrolate and neostigmine bromide product | rel=r_associated | relid=0 | w=20
  11. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:hemorrhagic disorders
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:hemorrhagic disorders | rel=r_associated | relid=0 | w=20
  12. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:hypertension
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:hypertension | rel=r_associated | relid=0 | w=20
  13. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:intestinal blockage
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:intestinal blockage | rel=r_associated | relid=0 | w=20
  14. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:intestinal obstruction
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:intestinal obstruction | rel=r_associated | relid=0 | w=20
  15. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:microphtalmia
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:microphtalmia | rel=r_associated | relid=0 | w=20
  16. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:parenteral form glycopyrrolate
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:parenteral form glycopyrrolate | rel=r_associated | relid=0 | w=20
  17. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:salivation inhibition
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:salivation inhibition | rel=r_associated | relid=0 | w=20
  18. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:splanchnemphraxis
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:splanchnemphraxis | rel=r_associated | relid=0 | w=20
  19. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:synchopexia
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:synchopexia | rel=r_associated | relid=0 | w=20
  20. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:tachyrhythmia
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:tachyrhythmia | rel=r_associated | relid=0 | w=20
  21. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:tachysystole
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:tachysystole | rel=r_associated | relid=0 | w=20
  22. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> en:ulcerative colitis
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=en:ulcerative colitis | rel=r_associated | relid=0 | w=20
  23. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> fréquence cardiaque élevée
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=fréquence cardiaque élevée | rel=r_associated | relid=0 | w=20
  24. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> obstruction intestinale
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=obstruction intestinale | rel=r_associated | relid=0 | w=20
  25. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> occlusion de l'intestin
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=occlusion de l'intestin | rel=r_associated | relid=0 | w=20
  26. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> occlusion intestinale
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=occlusion intestinale | rel=r_associated | relid=0 | w=20
  27. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> occlusion intestinale aigüe
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=occlusion intestinale aigüe | rel=r_associated | relid=0 | w=20
  28. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> rectocolite ulcérohémorragique
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=rectocolite ulcérohémorragique | rel=r_associated | relid=0 | w=20
  29. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> tachycardie
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=tachycardie | rel=r_associated | relid=0 | w=20
  30. en:glycopyrrolate 0.2mg/ml inj,syringe,3ml -- r_associated #0: 20 / 0.667 -> tachycardie, hypertension, microphtalmie et hyperglycinurie
    n1=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | n2=tachycardie, hypertension, microphtalmie et hyperglycinurie | rel=r_associated | relid=0 | w=20
≈ 41 relations entrantes

  1. en:bowel obstruction --- r_associated #0: 336 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:bowel obstruction | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=336
  2. en:intestinal obstruction --- r_associated #0: 335 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:intestinal obstruction | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=335
  3. occlusion intestinale --- r_associated #0: 332 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=occlusion intestinale | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=332
  4. obstruction intestinale --- r_associated #0: 255 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=obstruction intestinale | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=255
  5. en:splanchnemphraxis --- r_associated #0: 168 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:splanchnemphraxis | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=168
  6. occlusion de l'intestin --- r_associated #0: 155 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=occlusion de l'intestin | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=155
  7. en:tachycardia --- r_associated #0: 97 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:tachycardia | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=97
  8. tachycardie --- r_associated #0: 95 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=tachycardie | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=95
  9. battement rapide du coeur --- r_associated #0: 56 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=battement rapide du coeur | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=56
  10. fréquence cardiaque élevée --- r_associated #0: 56 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=fréquence cardiaque élevée | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=56
  11. en:synchopexia --- r_associated #0: 47 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:synchopexia | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=47
  12. en:parenteral form glycopyrrolate --- r_associated #0: 43 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:parenteral form glycopyrrolate | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=43
  13. en:glycopyrrolate 100%w/w powder --- r_associated #0: 42 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:glycopyrrolate 100%w/w powder | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=42
  14. en:tachyrhythmia --- r_associated #0: 42 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:tachyrhythmia | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=42
  15. tachycardie, hypertension, microphtalmie et hyperglycinurie --- r_associated #0: 42 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=tachycardie, hypertension, microphtalmie et hyperglycinurie | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=42
  16. occlusion intestinale aigüe --- r_associated #0: 40 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=occlusion intestinale aigüe | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=40
  17. rectocolite ulcérohémorragique --- r_associated #0: 36 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=rectocolite ulcérohémorragique | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=36
  18. en:angle closure glaucoma --- r_associated #0: 35 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:angle closure glaucoma | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=35
  19. en:ulcerative colitis --- r_associated #0: 34 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:ulcerative colitis | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=34
  20. en:tachysystole --- r_associated #0: 33 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:tachysystole | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=33
  21. colite ulcéreuse chronique --- r_associated #0: 31 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=colite ulcéreuse chronique | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=31
  22. en:hemorrhagic disorders --- r_associated #0: 31 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:hemorrhagic disorders | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=31
  23. en:intestinal blockage --- r_associated #0: 30 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:intestinal blockage | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=30
  24. en:salivation inhibition --- r_associated #0: 30 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:salivation inhibition | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=30
  25. en:decreased respiratory secretions --- r_associated #0: 29 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:decreased respiratory secretions | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=29
  26. en:glycopyrrolate 2mg tablet --- r_associated #0: 29 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:glycopyrrolate 2mg tablet | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=29
  27. en:hypertension --- r_associated #0: 27 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:hypertension | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=27
  28. en:microphtalmia --- r_associated #0: 27 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:microphtalmia | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=27
  29. en:glycopyrrolate 1mg tablet --- r_associated #0: 26 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:glycopyrrolate 1mg tablet | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=26
  30. en:glycopyrrolate and neostigmine bromide product --- r_associated #0: 26 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:glycopyrrolate and neostigmine bromide product | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=26
  31. en:and hyperglycinuria --- r_associated #0: 24 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:and hyperglycinuria | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=24
  32. en:intestinal occlusion --- r_associated #0: 24 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=en:intestinal occlusion | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=24
  33. colite ulcéreuse --- r_associated #0: 21 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=colite ulcéreuse | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=21
  34. Tachycardie --- r_associated #0: 20 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=Tachycardie | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=20
  35. Obstruction intestinale --- r_associated #0: 15 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=Obstruction intestinale | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=15
  36. Occlusion intestinale --- r_associated #0: 15 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=Occlusion intestinale | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=15
  37. hypertension --- r_associated #0: 10 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=hypertension | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=10
  38. recto-colite hémorragique --- r_associated #0: 10 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=recto-colite hémorragique | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=10
  39. rectocolite hémorragique --- r_associated #0: 10 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=rectocolite hémorragique | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=10
  40. taches blanches évanescentes (syndrome des) --- r_associated #0: 10 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=taches blanches évanescentes (syndrome des) | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=10
  41. Colite ulcéreuse --- r_associated #0: 5 --> en:glycopyrrolate 0.2mg/ml inj,syringe,3ml
    n1=Colite ulcéreuse | n2=en:glycopyrrolate 0.2mg/ml inj,syringe,3ml | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr